Balance Sheet Data

Salarius Pharmaceuticals, Inc. (SLRX)

$0.6901

-0.02 (-2.80%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 9.833.7411.1229.2112.1150.15100.25200.39400.56800.71
Total Cash (%)
Account Receivables 0.010.040.060.020.040.090.180.350.701.40
Account Receivables (%)
Inventories 0.190.771.170.410.821.643.286.5613.1126.20
Inventories (%)
Accounts Payable 1.111.791.851.542.865.6011.1922.3844.7389.41
Accounts Payable (%)
Capital Expenditure ---0-0-0-0-0.01-0.01-0.03-0.06
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.